Low activity of Yap-regulated CD4+ and CD8+ gene expression signatures correlated with immune infiltration in 19 TCGA cancer types—and strongly correlated with survival in 11 TCGA cancer types—highlighting that Yap activity in T cells has broad potential as a target for cancer therapy. Here, CD8A is linked to cancer.